Skip to main content

TNYA

Stock
Health Care
Biotechnology

Performance overview

TNYA Price
Price Chart

Forward-looking statistics

Beta
1.18
Risk
100.00%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration, and precision medicine.

Company info

SectorHealth Care
IndustryBiotechnology
Employees144
Market cap$285.8M

Fundamentals

Enterprise value$24.2M
Revenue$0.0
Revenue per employee—
Profit margin0.00%
Debt to equity10.81

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$1.15
Dividend per share—
Revenue per share—
Avg trading volume (30 day)$2M
Avg trading volume (10 day)$2M
Put-call ratio—

Macro factor sensitivity

Growth-4.2
Credit+8.7
Liquidity-0.4
Inflation-8.3
Commodities-5.1
Interest Rates-4.1

Valuation

Dividend yield0.00%
PEG Ratio-0.49
Price to sales—
P/E Ratio-0.49
Enterprise Value to Revenue—
Price to book0.83

Upcoming events

Next earnings dayMay 15, 2024
Next dividend day—
Ex. dividend day—

News

Should You Buy Tenaya Therapeutics, Inc. (TNYA) After Golden Cross?

After reaching an important support level, Tenaya Therapeutics, Inc. (TNYA) could be a good stock pick from a technical perspective. TNYA recently experienced a "golden cross" event, which saw its 50-day simple moving average breaking out above its 200-day simple moving average.

Zacks Investment Research (February 26, 2024)
Top 4 Health Care Stocks That Could Lead To Your Biggest Gains In Q3

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Benzinga (September 21, 2023)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free